Syncell, a leader in advanced subcellular protein purification and spatial proteomics analysis, has successfully closed a $15 million Series A funding round, bringing its total funding to $30 million. The…
MiSalud Health, a prominent digital health platform providing affordable, same-day bilingual (Spanish/English) telehealth consultations in both the United States and Mexico, has named co-founder Bismarck Lepe as the company’s new…
MiSalud Health, a prominent digital health platform offering affordable, same-day bilingual telehealth consultations (Spanish/English) in the U.S. and Mexico, has announced the appointment of co-founder Bismarck Lepe as CEO. Lepe…
Celltrion announced today that Health Canada has approved Omlyclo™, a biosimilar referencing Xolair®. Omlyclo™ is now approved for the treatment of adults and adolescents with chronic idiopathic urticaria (CIU), also…
Genentech, a member of the Roche Group, today announced five-year follow-up data from the pivotal Phase III POLARIX study. The study evaluated Polivy® (polatuzumab vedotin-piiq) in combination with Rituxan® (rituximab),…
Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) and the Institute for Follicular Lymphoma Innovation (IFLI) have entered into a strategic partnership to investigate the potential of IPH6501, Innate’s anti-CD20…
UroGen Pharma Ltd. (Nasdaq: URGN), a biotechnology company focused on developing innovative treatments for urothelial and specialty cancers, has announced the presentation of the Phase 3 ENVISION trial’s efficacy and…
BostonGene, a leader in AI-driven molecular and immune profiling solutions, has announced that 10 of its abstracts have been selected for poster presentations, and two will be featured for online…
Foresight Diagnostics, a leader in ultra-sensitive minimal residual disease (MRD) detection technology, has announced the launch of the SHORTEN-ctDNA clinical trial at Columbia University. The study aims to assess the…
Presidio Medical, Inc., a clinical-stage company focused on developing a groundbreaking neuromodulation platform, is excited to announce the appointment of Richard J. Buchholz to its Board of Directors. Rick currently…
Hyperfine, Inc. (Nasdaq: HYPR), a leader in health technology, showcased data at the Radiological Society of North America (RSNA) 2024 Annual Meeting in Chicago, highlighting the growing use of AI-powered…
ICON plc (NASDAQ: ICLR), a global leader in clinical research powered by healthcare intelligence, today revealed the results of a recent global survey involving 101 biotech and pharma professionals from…